prostate epithelial cells (hPREC) (Fig. 3C and fig.  S7D ). In contrast, overexpression of SPOP-WT suppressed sphere formation in this setting ( Fig. 3C  and fig. S7D ). Overexpression of DEK in hPREC cells also augmented sphere formation, whereas shRNA depletion of DEK (with three independent shRNAs) in cells overexpressing SPOP-87N impaired sphereforming capacity (Fig. 3D and fig. S7D ). Taken together, these data suggest that SPOP-dependent DEK regulation may promote a stemlike phenotype.
We then investigated whether the effects of SPOP mutations on DEK regulation might be generalizable across a broad spectrum of cancerassociated SPOP mutations. Here, we tested SPOP mutants from both prostate and endometrial cancer for their effects on DEK protein levels, collagen invasion, and sphere formation. All prostate cancer-associated SPOP mutants examined [representing >80% of mutations identified in this tumor type (1) ] conferred increased DEK protein expression, whereas two recurrent endometrial cancer-associated SPOP mutants (S80R and E50K) (2, 3) had no effect ( Fig. 4A and figs. S8A, S9A, and S10A) in prostate cells. As expected, DEK expression correlated with sphere-forming capacity and cell invasion without affecting baseline cell proliferation or viability (figs. S8, B and C, and S9B).
Finally, we considered whether other putative SPOP effector proteins-both known substrates and novel ones nominated by our ubiquitylome screen-might also undergo dysregulated expression in the setting of prostate cancer SPOP mutations (8, 9, (21) (22) (23) . Regarding the latter, we noted that TRIM24 represented another putative SPOP substrate from our screen with potential biological relevance to prostate cancer (Fig. 1 , B and C, and fig. S3C ) (10, 11) . As expected several known or putative SPOP substrates were downregulated in response to SPOP-WT overexpression (including DEK, TRIM24, NCOA3, DAXX, BRMS1, and GLI1 and 2) ( Fig. 4A and fig. S10A ). However, only DEK, TRIM24, and NCOA3 also became up-regulated upon overexpression of prostate cancer SPOP mutants in this setting (6) . Moreover, nuclear expression of these proteins correlated significantly with SPOP mutations in 181/178 primary prostate cancers analyzed by immunohistochemistry (Fig. 4 , B and C, and fig. S10B, table S3). These data are consistent with the ubiquitylome and experimental studies, which supports a model in which SPOP mutations may engage overlapping routes of transformation in prostate cancer by dysregulation of DEK, TRIM24, and NCOA3.
These data support a model wherein prostate cancer SPOP mutants impair ubiquitylation and degradation of a subset of SPOP substrates in a dominant-negative manner to promote tumorigenesis. Future studies of DEK dysregulation and its biological functions in normal and tumor tissue may therefore promote new biological insights relevant to many human cancers. More generally, large-scale profiling of the ubiquitin landscape linked to tumor genomic alterations in protein homeostasis genes may catalyze the identification of downstream effector mechanisms. Given the growing number of such genes identified by comprehensive cancer genome studies, this approach may provide an additional avenue for functional annotation of the cancer genome. In the future, these studies could uncover new biological and therapeutic avenues that exploit dysregulated protein homeostasis or ubiquitinbased regulation in cancer. (1, 2) . Recent studies have suggested that age-related changes in both circulating soluble factors (3) (4) (5) and peripheral immunity (6) are involved in this process. Nevertheless, given the fact that the mammalian central nervous system (CNS) is secluded behind barriers from directly interacting with the blood circulation (7), the underlying mechanism remains unclear.
The choroid plexus (CP), an epithelial monolayer that forms the blood-cerebrospinal fluid (CSF) barrier and produces the CSF (8), serves as a neuroimmunological interface in shaping brain function in health and pathology by integrating signals from the brain with signals coming from the circulation (6, 9-11). We envisioned that understanding how CP activity is altered in aging might lead to identification of strategies to attenuate aging-associated cognitive decline.
To determine whether aging of the CP reflects aging of the brain and other body tissues, we systematically characterized the mRNA expression profile of young (3-month-old) and aged (22-month-old) murine organs by RNA sequencing. Whereas all examined tissues from aged mice showed increased expression of mRNA transcripts associated with age-related processes, such as immune response (P = 2.66 × 10 ; cluster IX; Fig. 1A and fig. S1 , A to C), classically associated with antiviral activity (12) . To exclude an aging-unrelated effect such as viral infection, we confirmed the increased expression of IFN-I-dependent genes [e.g., IFN regulatory factor 7 (irf7), IFN-b 1 (ifnb), and IFN-induced protein with tetratricopeptide repeats 1 (ifit1)] by real-time quantitative polymerase chain reaction (qPCR) in different cohorts of aged mice from various animal centers (Fig. 1B) . Closer examination by qPCR and immunohistochemical staining showed that, whereas IFN-I-associated gene expression was increased in the aged CP, expression of type II IFN (IFN-g)-dependent genes (10) [e.g., intercellular adhesion molecule 1 (icam1), IFN-g-induced protein 10 (cxcl10), and chemokine (C-C motif) ligand 17 (ccl17)] was decreased ( Fig. 1, C and D) . Immunohistochemical staining of brain sections of mice, as well as postmortem brain sections from non-CNS-diseased humans, confirmed an agingassociated increase of IFN-I at the CP (Fig. 1E ) and suggested that this signature is conserved among species.
The CP epithelium is exposed to brain-derived signals from its apical side, via the CSF, and to peripheral signals from its basal side, via the circulation (8) . To differentially examine which of these compartments induces the transcriptional signature of the aged CP, we used a heterochronic parabiosis model (13) , in which young and aged mice were surgically connected to share vasculature. Under these conditions, there are bidirectional, although not symmetric, effects on hippocampal neurogenesis and cognitive function between young and aged heterochronic parabionts (3, 4) . Transcriptome analyses revealed that the circulation of aged mice failed to induce expression of IFN-I-dependent genes in the CP of young heterochronic partners. It did, however, affect expression of IFN-II-dependent genes, including reduced expression of homing and trafficking determinants required for physiological leukocyte entry via the CP to the CSF [ Fig. 2, A  and B, and fig. S2 , A and B (clusters III and VIII)] (10) and increased expression of ccl11 (Fig. 2C) , a chemokine that impairs brain plasticity (3), and its expression by the CP is induced by the cytokine interleukin (IL)-4 when local IFN-g levels are diminished (6) . Under the same experimental setting, the young circulation failed to reverse the expression program of IFN-I-dependent genes in the aged CP yet affected expression of IFN-II-dependent genes (10) (Fig. 2, A and B, and fig.  S2, A and B) . However, CCL11 expression by the CP of the aged heterochronic parabionts was not affected by the young circulation (Fig. 2C) , suggesting that IFN-II regulation of CCL11 expression in the aged CP involves additional factors that are not derived from the circulation. These results indicated that the IFN-II expression program at the aged CP is modulated by both circulation-and brain-derived factors, whereas IFN-I in this compartment might be induced by factors in the CSF emitted from the aged brain. Therefore, we exposed primary cultures of CP epithelial cells of young mice to CSF aspirated from aged or young mice; we found that the CSF of aged but not of young mice induced the IFN-I-dependent response (Fig. 2D) . This response was recapitulated when epithelial cells of the CP were treated with a mixture of proinflammatory cytokines that accumulate in the brain during aging and neurodegeneration (14) (fig. S3) .
The apparent inverse relations between type I and type II IFN expression programs in the aged CP ( Figs. 1 and 2 whether it involves interfering with local IFN-IIdependent activities. In vitro exposure of CP epithelial cells to the major IFN-I cytokine, IFN-b, induced a classical "antiviral" response ( Fig. 3A) and resulted in reduced expression of insulin-like growth factor (igf1) and brain-derived neurotrophic factor (bdnf) (Fig. 3B) , molecules that support neuronal growth, differentiation, and survival and are produced by the CP (11) . In vivo administration of neutralizing antibodies to the IFN-I receptor (a-IFNAR) to the CSF of aged mice blocked the IFN-I response program at the CP (Fig. 3C) and resulted in restoration of igf1 and bdnf expression (Fig. 3D and  fig. S6 ), as well as ccl11 expression (Fig. 3E) , to levels similar to those found in the CP of young To determine whether in vivo neutralization of IFN-I in aging could reverse cognitive dysfunction, we assessed two different measurements of brain plasticity, hippocampal-dependent spatial memory and hippocampal neurogenesis (19) (Fig. 4A) . Because age-associated cognitive decline varies across individuals, we first scored memory ability in aged mice by the novel location recognition (NLR) task, in which animals explore two objects, and the exploration time of each object is measured. After 24 hours, one of the objects is relocated, and mice with normal memory spend more time exploring the displaced object, compared with the object that was not moved (20) . Cognitively impaired aged mice selected this way (Fig. 4, A and B, and fig. S7 ) received either a-IFNAR or immunoglobulin G (IgG) injected into their CSF and were tested again in new settings of an NLR test. a-IFNARtreated mice, unlike the control group, showed improved memory (Fig. 4C) , suggesting that neutralizing IFN-I signaling within the brain could restore cognitive function in aged mice. Moreover, the number of newborn neurons, stained for 5-bromo-2'-deoxyuridine (BrdU) (21) and doublecortin (DCX), was increased in the hippocampus of the a-IFNAR-treated group (Fig. 4D) , reaching levels comparable to those of aged mice that maintained cognitive function; enhanced hippocampal neurogenesis to a similar extent in aged mice was correlated with improved cognitive function (4) . Examination of the hippocampal parenchyma for the effect on age-related neuroinflammation (2), which detrimentally affects adult neurogenesis (22, 23) , revealed increased mRNA expression of the anti-inflammatory cytokine, IL-10 ( Fig. 4E) , and a marked decrease in astrogliosis and microgliosis (Fig. 4, F and G) in the a-IFNARtreated group.
Although originally identified by their antiviral properties, type I IFNs have important roles in attenuating inflammation, both outside and inside the CNS (24) (25) (26) . Nevertheless, we found that blocking IFN-I signaling in the brain of aged mice partially restored cognitive function and hippocampal neurogenesis and attenuated agerelated chronic neuroinflammation. It is thus possible that the IFN-I response program at the aged CP represents a physiological mechanism evoked to mitigate age-related neuroinflammation. When this process is not timely terminated, it becomes detrimental to brain plasticity, at least in part by interfering with IFN-II activity in the CP and brain parenchyma, which is needed for physiological immune-dependent brain maintenance and resolution of neuroinflammation in aging and pathology (6, 9, 10, 27-29) (fig. S8) . Other blood-brain interfaces may undergo similar changes in aging. Our findings may shed light on the association between cerebral levels of IFN-I and memory impairments in several human diseases (25) and the neurological and neuropsychiatric complications that often accompany IFN-I administration to patients (30) . Therefore, neutralizing the response to type I IFNs within the CNS might provide an approach to reverse or slow down age-associated cognitive decline or other pathological conditions associated with chronic IFN-I within the CNS.
T CELL MEMORY
A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells Norifumi Iijima and Akiko Iwasaki* CD8 tissue-resident memory T (T RM ) cells provide efficient local control of viral infection, but the role of CD4 T RM is less clear. Here, by using parabiotic mice, we show that a preexisting pool of CD4 T RM cells in the genital mucosa was required for full protection from a lethal herpes simplex virus 2 (HSV-2) infection. Chemokines secreted by a local network of macrophages maintained vaginal CD4 T RM in memory lymphocyte clusters (MLCs), independently of circulating memory T cells. CD4 T RM cells within the MLCs were enriched in clones that expanded in response to HSV-2. Our results highlight the need for vaccine strategies that enable establishment of T RM cells for protection from a sexually transmitted virus and provide insights as to how such a pool might be established. E ffector memory T cells circulate throughout the peripheral tissues, and although they are sufficient to provide protection against systemic infections (1-4), they cannot control infection localized to peripheral tissues (4-6). After viral skin infection, CD8 tissue-resident memory T (T RM ) cells control infection more efficiently than circulating CD8 T cells (7) (8) (9) (10) and recruit circulating T cells to the sites of infection (11) . In contrast to CD8 T RM cells, little is known regarding the existence or importance of CD4 T RM cells. Unlike CD8 T cells, memory CD4 T cells readily traffic through circulation to provide protection at distal sites (12) . Respiratory infection with influenza virus induces protective CD4 T cells capable of migrating and establishing residency in the lung (13) . However, to what extent resident versus circulating memory CD4 T cells are required for protection of the host and the mechanism by which such a memory pool is maintained are unclear.
To address these questions, we used a mouse model of genital herpes. Intravaginal (ivag) immunization with an attenuated herpes simplex virus 2 (HSV-2) strain [thymidine kinase-negative (TK) -HSV-2] results in complete protection from secondary challenge with wild-type (WT) HSV-2 (14) . TK -HSV-2 replicates in the vaginal keratinocytes and establishes latent infection in the dorsal root ganglia but does not reactivate (15) . The protective memory response to HSV-2 vaginal challenge requires CD4 T cells that secrete the cytokine interferon-g (IFN-g) but does not require either CD8 T cells or B cells (16) . Although all routes of immunization induced systemic CD4 T cell responses, only ivag immunization with TK -HSV-2 recruited significant numbers of viral-specific CD4 T cells to the vagina (17, 18) and conferred protection against lethal disease ( fig. S1 ), which indicated that the local immunization is required to mount protective immunity.
To examine the selective ability of local immunization to confer protective immunity, we used parabiotic mice. Full chimerism was achieved in systemic circulation within 2 weeks of parabiosis ( fig. S2) (19) . The vaginal memory pool, analyzed 6 weeks after parabiosis of ivag TK -HSV-2 immune pairs, was largely disconnected from the rest of the circulation (Fig. 1A) . Host-derived CD4 T RM cells were mainly distributed within memory lymphocyte clusters (MLCs), whereas the rare donor-derived circulating CD4 T cells were found at the periphery of the MLCs (Fig. 1B) . In contrast, CD8 T RM cells resided within the epithelium and within the MLCs, and circulating CD8 T cells were rarely found (Fig. 1B) . Within the MLCs, CD11c + and major histocompatibility complex (MHC) class II + cells were present ( fig. S3, A and  B) . Unlike the tertiary lymphoid organs that contain peripheral node addressin-positive (PNAd + ) high endothelial venules and a developed lymphatic endothelial network (20) , PNAd + blood vessels and lymphatic vessel endothelial hyaluronic acid receptor 1-positive (LYVE-1 + ) lymphatic endothelial vessels were not found within the MLCs (fig. S3) . Other features typical of tertiary lymphoid tissues were also absent, such as germinal center B cells ( fig. S3D ) and naïve lymphocytes ( fig. S4C ).
HSV-2-specific CD4 + T RM cells were T cell receptor ab-positive (TCRab + ) ( fig. S4A ) and secreted IFN-g, tumor necrosis factor-a (TNF-a), and interleukin 2 (IL-2) ( fig. S4B) 
